Seyed Mahdi Hassanian Selected Research

Menstruation Disturbances

1/2019	Therapeutic potency of crocin in the treatment of inflammatory diseases: Current status and perspective.
4/2018	Crocus sativus a natural food coloring and flavoring has potent anti-tumor properties.
12/2017	Saffron against Components of Metabolic Syndrome: Current Status and Prospective.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seyed Mahdi Hassanian Research Topics

Disease

81	Neoplasms (Cancer) 08/2022 - 01/2016
34	Colorectal Neoplasms (Colorectal Cancer) 08/2022 - 01/2017
20	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2017
16	Inflammation (Inflammations) 01/2022 - 02/2014
16	Breast Neoplasms (Breast Cancer) 09/2020 - 01/2017
9	Fibrosis (Cirrhosis) 01/2022 - 01/2020
9	Colonic Neoplasms (Colon Cancer) 10/2021 - 01/2017
9	Carcinogenesis 09/2020 - 01/2016
9	Cardiovascular Diseases (Cardiovascular Disease) 02/2020 - 03/2017
7	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2016
5	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 04/2021 - 10/2017
4	Necrosis 12/2022 - 01/2021
4	Adenocarcinoma 10/2018 - 01/2016
3	Liver Diseases (Liver Disease) 09/2022 - 12/2017
3	Diarrhea 06/2022 - 09/2020
3	Stomach Neoplasms (Stomach Cancer) 03/2022 - 01/2016
3	Colitis 01/2022 - 05/2020
3	Polyps 10/2021 - 02/2014
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2020 - 12/2017
3	Melanoma (Melanoma, Malignant) 02/2019 - 01/2016
3	Carcinoma (Carcinomatosis) 02/2019 - 01/2018
3	Menstruation Disturbances 01/2019 - 12/2017
3	Drug-Related Side Effects and Adverse Reactions 01/2019 - 01/2018
2	Vomiting 06/2022 - 01/2021
2	Nausea 06/2022 - 01/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2021 - 02/2019
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2019
2	Edema (Dropsy) 01/2020 - 01/2020
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 01/2019
2	Atherosclerosis 01/2019 - 01/2019
2	Atherosclerotic Plaque (Atheroma) 01/2019 - 01/2018
2	Colitis-Associated Neoplasms 12/2018 - 10/2018
2	Asthma (Bronchial Asthma) 04/2018 - 12/2017

Drug/Important Bio-Agent (IBA)

31	Biomarkers (Surrogate Marker)IBA 09/2022 - 01/2016
17	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2016
15	Fluorouracil (Carac)FDA LinkGeneric 08/2022 - 01/2017
9	Proteins (Proteins, Gene)FDA Link 05/2020 - 01/2017
7	Pharmaceutical PreparationsIBA 08/2022 - 01/2016
7	CateninsIBA 08/2022 - 01/2017
6	CytokinesIBA 12/2022 - 02/2015
6	Biological ProductsIBA 03/2022 - 01/2019
6	Angiotensin Receptor AntagonistsIBA 01/2022 - 01/2020
6	crocinIBA 07/2021 - 12/2017
6	Thrombin FDA Link 01/2019 - 09/2014
5	Adenosine (Adenocard)FDA LinkGeneric 01/2019 - 09/2014
5	CurcuminIBA 10/2018 - 01/2017
4	Angiotensin IIIBA 01/2022 - 01/2018
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 01/2018
4	CollagenIBA 01/2022 - 01/2020
4	AntioxidantsIBA 10/2021 - 01/2019
4	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019 - 02/2014
3	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2022 - 01/2019
3	Cyclin D1IBA 08/2022 - 01/2018
3	Cadherins (E-Cadherin)IBA 08/2022 - 01/2019
3	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022 - 01/2018
3	Valsartan (Vals)FDA Link 01/2022 - 01/2022
3	Gemcitabine FDA Link 01/2022 - 01/2017
3	Peptides (Polypeptides)IBA 10/2021 - 01/2018
3	Oxidants (Oxidizing Agents)IBA 10/2021 - 01/2021
3	Sulfhydryl Compounds (Thiols)IBA 01/2021 - 10/2018
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 01/2018
3	Losartan (Cozaar)FDA LinkGeneric 01/2021 - 01/2018
3	Long Noncoding RNAIBA 11/2019 - 11/2018
3	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2019 - 03/2018
2	Interleukin-6 (Interleukin 6)IBA 12/2022 - 01/2020
2	PNU-74654IBA 08/2022 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2022 - 01/2019
2	SurvivinIBA 08/2022 - 01/2021
2	InterferonsIBA 04/2022 - 01/2017
2	AngiotensinsIBA 01/2022 - 01/2022
2	candesartanIBA 01/2022 - 01/2021
2	Telmisartan (Micardis)FDA Link 01/2022 - 01/2020
2	PolyphosphatesIBA 10/2021 - 02/2014
2	Immune Checkpoint InhibitorsIBA 04/2021 - 02/2019
2	Hematoxylin (Haematoxylon)IBA 01/2021 - 01/2021
2	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 07/2020
2	ON 01910IBA 01/2021 - 05/2020
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2021 - 01/2021
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 08/2020 - 01/2018
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 03/2018
2	Mitogen-Activated Protein KinasesIBA 01/2020 - 01/2018
2	Vitamin D FDA LinkGeneric 01/2020 - 12/2019
2	Adenylate KinaseIBA 12/2019 - 01/2018
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2019 - 01/2018
2	LigandsIBA 10/2019 - 01/2019
2	Calcibiotic Root Canal SealerIBA 02/2019 - 01/2019
2	HSP27 Heat-Shock ProteinsIBA 01/2019 - 08/2017
2	LipidsIBA 01/2019 - 01/2017
2	CholesterolIBA 01/2019 - 08/2017
2	CarcinogensIBA 01/2019 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2017
2	AntigensIBA 01/2019 - 08/2017
2	EnzymesIBA 11/2018 - 10/2018
2	Death Domain ReceptorsIBA 10/2018 - 01/2017
2	safranalIBA 04/2018 - 12/2017

Therapy/Procedure

28	Therapeutics 01/2022 - 10/2017
9	Drug Therapy (Chemotherapy) 10/2021 - 01/2016
3	Radiotherapy 01/2019 - 01/2017
2	Intravenous Injections 01/2022 - 01/2020
2	Traditional Medicine (Folk Remedies) 04/2018 - 12/2017